Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
20.28
-0.37 (-1.79%)
At close: Dec 5, 2025, 4:00 PM EST
20.17
-0.11 (-0.57%)
After-hours: Dec 5, 2025, 5:23 PM EST
Dyne Therapeutics Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for Dyne Therapeutics stock have an average target of 36.53, with a low estimate of 11 and a high estimate of 50. The average target predicts an increase of 80.13% from the current stock price of 20.28.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Dyne Therapeutics stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 7 | 7 |
| Buy | 10 | 8 | 8 | 6 | 6 | 6 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 15 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | -16.17% | Nov 14, 2025 |
| Oppenheimer | Oppenheimer | Hold Maintains $13 → $11 | Hold | Maintains | $13 → $11 | -45.76% | Nov 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $38 → $46 | Strong Buy | Maintains | $38 → $46 | +126.82% | Nov 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $23 → $30 | Buy | Maintains | $23 → $30 | +47.93% | Nov 6, 2025 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades $13 | Buy → Hold | Downgrades | $13 | -35.90% | Oct 10, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.61
from -3.37
EPS Next Year
-3.40
from -3.61
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.51 | -2.44 | ||||
| Avg | -3.61 | -3.40 | ||||
| Low | -3.75 | -4.23 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.